Pharmacokinetics and tolerability of ascending intravenous doses of granisetron, a novel 5-HT3 antagonist, in healthy human subjects
- 1 March 1994
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 46 (2) , 159-162
- https://doi.org/10.1007/bf00199881
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- GranisetronDrugs, 1991
- The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist.1990
- A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic responseCancer Chemotherapy and Pharmacology, 1989
- Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonistBritish Journal of Cancer, 1988